Aprea Therapeutics, Inc.
For the period ended Jun 5, 2025. Filed Apr 22, 2025.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Jun 5, 2025 · Filed Apr 22, 2025
APRE$0.52+4.5%Stored close · as of Nov 6, 2026
Contents
EVALUATING BOARD EFFECTIVENESS
The Board of Directors is committed to continuous improvement and periodic self-evaluations are an important tool for evaluating effectiveness. The Board and each Committee plan to conduct a rigorous periodic self-evaluation of their performance and effectiveness.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.